Title: Weight Loss Medication Ozempic Found to Reduce Alcohol Cravings: Promising Discovery for Alcohol Use Disorder Treatment
Las Vegas, NV – A surprising side effect of the weight loss medication Ozempic has been discovered by Christie Martin, a realtor and mother. Not only did she shed over 30 pounds, but she also experienced a decreased desire to consume alcohol. This unexpected finding has sparked interest in using Ozempic and its active ingredient, semaglutide, for treating alcohol use disorder.
Martin found that after starting Ozempic, her cravings for alcohol vanished, even to the extent of declining a glass at dinner and avoiding buying bottles altogether. Her experience aligns with a small case study where six individuals with alcohol use disorder reported a significant decrease in symptoms while using semaglutide, which is also found in another weight loss drug called Wegovy.
Semaglutide, a GLP-1 receptor agonist commonly used for weight loss, has demonstrated a potential impact on addictive behaviors, specifically alcohol use disorder. This effect is believed to stem from its interaction with the brain’s reward center, affecting the cravings associated with alcohol consumption.
Alcohol use disorder is a widespread medical condition, affecting nearly 30 million people in the United States. Current treatments include FDA-approved medications, behavioral interventions, and tech-based therapies. However, it is crucial for individuals with this disorder to explore multiple forms of treatment to achieve significant lifestyle changes.
Unfortunately, the use of semaglutide medications for alcohol use disorder is considered off-label, meaning it is not officially approved for this indication. Consequently, insurance coverage for this treatment option is unlikely, making it financially burdensome for most individuals.
While the initial findings appear promising, stronger scientific evidence is needed before semaglutide can be established as a reliable treatment for alcohol use disorder. Results from clinical trials are expected at least a year from now and will require regulatory approval. Until then, individuals concerned about their alcohol use can rely on the free and confidential helpline offered by SAMHSA (Substance Abuse and Mental Health Services Administration) for support available 24/7.
This news article was contributed by Dr. Jade A. Cobern, a member of the ABC News Medical Unit.
Word Count: 334 words
“Prone to fits of apathy. Devoted music geek. Troublemaker. Typical analyst. Alcohol practitioner. Food junkie. Passionate tv fan. Web expert.”